ES2061727T3 - PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. - Google Patents
PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.Info
- Publication number
- ES2061727T3 ES2061727T3 ES88810760T ES88810760T ES2061727T3 ES 2061727 T3 ES2061727 T3 ES 2061727T3 ES 88810760 T ES88810760 T ES 88810760T ES 88810760 T ES88810760 T ES 88810760T ES 2061727 T3 ES2061727 T3 ES 2061727T3
- Authority
- ES
- Spain
- Prior art keywords
- physiologically active
- active substances
- procedure
- contain
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Abstract
The present invention relates to physiologically active substances extracted from infected tissues inoculated with a poxvirus. The substances of the present invention have excellent actions to improve blood flow and recover functions of diseased tissues, thus are useful as drugs for various diseases caused by blood flow disorders.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28176487 | 1987-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2061727T3 true ES2061727T3 (en) | 1994-12-16 |
Family
ID=17643645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88810760T Expired - Lifetime ES2061727T3 (en) | 1987-11-06 | 1988-11-07 | PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |
Country Status (5)
Country | Link |
---|---|
US (1) | US4985254A (en) |
EP (1) | EP0315591B1 (en) |
AT (1) | ATE87484T1 (en) |
DE (1) | DE3879873T2 (en) |
ES (1) | ES2061727T3 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE94401T1 (en) * | 1988-04-30 | 1993-10-15 | Nippon Zoki Pharmaceutical Co | PHYSIOLOGICAL SUBSTANCES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THEREOF. |
JP2588109B2 (en) * | 1993-03-19 | 1997-03-05 | 日本臓器製薬株式会社 | Painkillers |
JP3213832B2 (en) * | 1993-08-06 | 2001-10-02 | 日本臓器製薬株式会社 | Test substance activity measurement method |
JP3213831B2 (en) * | 1993-08-06 | 2001-10-02 | 日本臓器製薬株式会社 | Test substance activity measurement method |
JP2594222B2 (en) * | 1993-09-28 | 1997-03-26 | 日本臓器製薬株式会社 | New physiologically active substance-KF |
AU721804B2 (en) * | 1997-01-08 | 2000-07-13 | Nippon Zoki Pharmaceutical Co., Ltd. | Nitrogen monoxide production suppressor |
JP4033936B2 (en) * | 1997-01-08 | 2008-01-16 | 日本臓器製薬株式会社 | Nitric oxide production inhibitor |
JPH1180005A (en) * | 1997-09-12 | 1999-03-23 | Nippon Zoki Pharmaceut Co Ltd | Therapeutic agent for osteoporosis |
KR19990044835A (en) | 1997-11-28 | 1999-06-25 | 고니시 진우에몬 | Herbal Extract |
CA2270050A1 (en) * | 1998-04-27 | 1999-10-27 | Jin-Emon Konishi | A therapeutic agent for ischemic diseases |
CN1272365A (en) | 1999-04-15 | 2000-11-08 | 日本脏器制药株式会社 | Physiological active material |
US6726932B2 (en) | 2000-02-18 | 2004-04-27 | Nippon Zoki Pharmaceutical Co., Ltd. | Fatty acid-containing composition |
US6913900B2 (en) * | 2001-08-29 | 2005-07-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Plasma prekallikrein activation and kallikrein production assay |
CN1207005C (en) * | 2002-10-31 | 2005-06-22 | 威世药业(如皋)有限公司 | Rabbit skin containing bioactive substance and its use |
KR101307999B1 (en) | 2004-12-01 | 2013-09-12 | 니폰 조키 세야쿠 가부시키가이샤 | Dried material and method for the manufacture thererof |
US20060134646A1 (en) * | 2004-12-17 | 2006-06-22 | Ansari Aftab A | Method for treatment of HIV infection |
WO2007090081A2 (en) * | 2006-01-27 | 2007-08-09 | The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations | Analysis of mycophenolic acid in saliva using liquid chromatography tandem mass spectrometry |
CN101732348B (en) | 2008-11-11 | 2015-01-14 | 威世药业(如皋)有限公司 | Application of varicella vaccine inflammation induced rabbit fur extractive in preparing medicaments for treating acute cerebrovascular diseases |
TWI483729B (en) | 2010-03-11 | 2015-05-11 | Nippon Zoki Pharmaceutical Co | Improving or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urinary disturbance |
CA2808927C (en) | 2010-10-14 | 2018-10-30 | Nippon Zoki Pharmaceutical Co., Ltd. | A method for promoting the synthesis of collagen and proteoglycan in chondrocytes |
KR102182240B1 (en) | 2013-04-30 | 2020-11-24 | 니폰 조키 세야쿠 가부시키가이샤 | Extract, and preparation containing said extract |
CN106573020A (en) * | 2014-08-08 | 2017-04-19 | 加利福尼亚大学董事会 | A liver protecting method and a liver protecting agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5835117A (en) * | 1981-08-25 | 1983-03-01 | Nippon Zoki Pharmaceut Co Ltd | Novel physiologically active substance, nsh |
JP2651674B2 (en) * | 1987-07-23 | 1997-09-10 | 日本臓器製薬 株式会社 | New physiologically active substance and method for producing the same |
FR2649273B1 (en) * | 1989-06-30 | 1991-09-13 | Portenseigne Radiotechnique | SELF-ADAPTIVE EQUALIZATION DEVICE FOR DUOBINALLY CODED DIGITAL SAMPLES |
JP3469377B2 (en) * | 1995-10-25 | 2003-11-25 | 信越化学工業株式会社 | Method for producing vinyl chloride polymer |
-
1988
- 1988-11-03 US US07/266,758 patent/US4985254A/en not_active Expired - Lifetime
- 1988-11-07 ES ES88810760T patent/ES2061727T3/en not_active Expired - Lifetime
- 1988-11-07 AT AT88810760T patent/ATE87484T1/en active
- 1988-11-07 EP EP88810760A patent/EP0315591B1/en not_active Expired - Lifetime
- 1988-11-07 DE DE8888810760T patent/DE3879873T2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE87484T1 (en) | 1993-04-15 |
DE3879873T2 (en) | 1993-08-05 |
EP0315591B1 (en) | 1993-03-31 |
US4985254A (en) | 1991-01-15 |
EP0315591A2 (en) | 1989-05-10 |
EP0315591A3 (en) | 1990-05-16 |
DE3879873D1 (en) | 1993-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2061727T3 (en) | PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2045182T3 (en) | PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCESS FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
IT1241996B (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISORDERS AND METHOD FOR ITS APPLICATION. | |
ATE204178T1 (en) | METHOD FOR TREATING AND PREVENTING TYPE 1 DIABETIS BY ORAL ADMINISTRATION OF INSULIN | |
BR9714363A (en) | Substituted pyrazole derivatives for the treatment of cardiac circulatory diseases | |
PT88985A (en) | Process for the preparation of nasal and ophthalmic pharmaceutical compositions containing azelastine | |
RU94002475A (en) | Pharmaceutical composition and its use for viral infection treatment | |
HUP0203437A2 (en) | Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases | |
FR2512670B1 (en) | CAPSULES CONTAINING THE ACTIVE INGREDIENT OF AN ALLERGEN AND PROCESS FOR THEIR PREPARATION | |
ES2058592T3 (en) | THE USE OF PHYSIOLOGICALLY ACTIVE SUBSTANCES FOR THE MANUFACTURE OF MEDICINES FOR BRAIN AND NEURONAL DISEASES. | |
DE69002718T2 (en) | Medication. | |
DE68929388D1 (en) | Anticoagulant compound isolated from urine | |
IT8322855A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE. | |
ATE20309T1 (en) | PHARMACEUTICAL PREPARATION. | |
MX163574B (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR INHALATION CONTAINING A GANGLIOSIDE | |
ES2059816T3 (en) | PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS OF THE SAME. | |
ATE174798T1 (en) | THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION DISEASES | |
SE8704952D0 (en) | PHARMACEUTICAL COMPOSITION | |
HUP0202525A2 (en) | Mycophenolate mofetil in association with peg-ifn-alpha, medicaments and kit comprising thereof | |
DE69621786D1 (en) | AMINOTETRAL IN DERIVATIVE FOR THE TREATMENT OF HEART CIRCULAR DISEASE | |
KR890012942A (en) | 5-substituted ornithine derivatives | |
ATE230997T1 (en) | CHAMOMILE DRUG AND USE THEREOF FOR PRODUCING CHAMOMILE EXTRACTS, CHAMOMILE OIL AND PHARMACEUTICAL PRODUCTS | |
DE69011857D1 (en) | Use of GnRH-analog for the manufacture of a medicament for the treatment of motility disorders. | |
SE7708622L (en) | 2-BENZYL-PERHYDROAZEPINES, PREPARATIONS AND MEDICINAL PRODUCTS, CONTAINING THEM | |
BR0105968A (en) | Natural medicine for alternative anti-HIV treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 315591 Country of ref document: ES |